ClinConnect ClinConnect Logo
Search / Trial NCT06971861

Just ACT for Student Well-being

Launched by THE UNIVERSITY OF HONG KONG · May 6, 2025

Trial Information

Current as of August 20, 2025

Recruiting

Keywords

ClinConnect Summary

The "Just ACT for Student Well-being" trial is a study looking at a new program designed to help young people manage stress and improve their mental health. Since many psychological issues start during the teenage years, this program aims to guide young individuals in living according to their personal values, which can support their overall well-being. The program will be brief and focuses on prevention, giving youths tools to handle challenges they may face.

To participate, you need to be 35 years old or younger and be able to read and speak Chinese. However, individuals with certain mental health conditions, like psychosis or bipolar disorder, or those who have had recent thoughts of suicide, will not be eligible to join. The trial is not yet recruiting participants, but once it starts, those selected will have the chance to learn valuable skills to help them navigate the stresses of adolescence.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age of 35 years or below
  • fluency in oral and written Chinese
  • Exclusion Criteria:
  • active or current history of psychosis, bipolar disorder, or personality disorder
  • active or current report of suicidal attempts
  • active or current suicidal ideations for more than half the days
  • any history of intellectual deficits

About The University Of Hong Kong

The University of Hong Kong (HKU) is a leading research institution dedicated to advancing medical knowledge and improving healthcare outcomes through innovative clinical trials. With a commitment to excellence in research and education, HKU collaborates with various stakeholders, including healthcare providers and industry partners, to conduct rigorous and ethically sound clinical studies. The university's diverse expertise and state-of-the-art facilities enable it to explore a wide range of therapeutic areas, contributing to the global pursuit of scientific advancement and the development of novel treatment strategies.

Locations

Hong Kong, , Hong Kong

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported